Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-04
1997-03-11
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 530380, 530382, 530383, A61K 3839
Patent
active
056101481
ABSTRACT:
A porous macroscopically undirectionally oriented cell adhesion protein may be used to promote and direct wound healing.
REFERENCES:
patent: 4703108 (1987-10-01), Silver et al.
patent: 4885295 (1989-12-01), Bell
patent: 4925924 (1990-05-01), Silver et al.
patent: 4955892 (1990-09-01), Daniloff
patent: 4970298 (1990-11-01), Silver et al.
patent: 4973466 (1990-11-01), Reich
patent: 4983580 (1991-01-01), Gibson et al.
patent: 5013732 (1991-05-01), Bell
patent: 5043288 (1991-08-01), Motsenbocker
patent: 5043429 (1991-08-01), Zimmerman
patent: 5104856 (1992-04-01), Esko et al.
patent: 5120828 (1992-06-01), Charonis
patent: 5124155 (1992-06-01), Reich
Caffesse, R. C. et al., "The effect of citric acid & fibronectin . . . ", J. Clin. Periodontol., vol. 12(7), pp. 578-590, 1985.
Clark, R. A. F, "Fibronectin matrix deposition and fibronectin . . . ", J. Invest. Dermatol., 94/6 Suppl., pp. 128S-134S, 1990.
Grinnell, F et al., "Distribution of Fibronectin during wound . . . ", J. Invest. Dermatol., vol. 76(3), 1981, pp. 181-189.
Baur, Paul et al., "The myofibroblast anchoring strand . . . ", J. Trauma, vol. 23(10), pp. 853-862, 1983.
Caffesse, R. G. et al., J. Clin. Periodontol., vol. 12(7), pp. 578-590, 1985.
Chiquet et al: "Muschle morphogenesis: Evidence for anorganizing function of exogenous fibronectin"; Developmental Biology, vol. 88, No. 2, Dec. 1981, pp. 220-235 (especially p. 230--col. 2--p. 234).
Simmons, "Evaluation of collagen cross-linking techniques for the stabilization of tissue matrices", Biotechnol-Appl-Biochem., 1993 Feb.; 17 (Pt 1):23-9.
Freed, "Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease", N. Engl. J. Med., 1992 Nov. 26; 327(22):1549-55.
Gershon, "Compliance and ultimate strength of composite arterial prostheses", Biomaterials, 1992; 13(1):38-43.
Ricci, "In-vitro tendon cell growth on synthetic fiber implant materials: biological implications", Bull. Hosp. Jt. Dis. Orthop. Inst., 1990 Fall; 50(2):126-38.
Matsuda, "Development of a novel artificial matrix with cell adhesion peptides for cell culture and artificial and hybrid organs", ASAIO. Trans. 1989 Jul.-Sep.; 35(3):677-9.
Jakobson, "A simple method for shell-less cultivation of chick embryos", Pharmacol-Toxicol. 1989 Feb.; 64(2):193-5.
Brown, "Therapeutic Uses of Cell-Matrix Adhesive Proteins", Current Opinion in Therapeutic Patents, Aug. 1993, pp. 1117-1140.
Sayala Chhaya D.
University College London
LandOfFree
Macroscopically oriented cell adhesion protein for wound treatme does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macroscopically oriented cell adhesion protein for wound treatme, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macroscopically oriented cell adhesion protein for wound treatme will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-443662